These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883 [TBL] [Abstract][Full Text] [Related]
3. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma. Virga J; Bognár L; Hortobágyi T; Zahuczky G; Csősz É; Kalló G; Tóth J; Hutóczki G; Reményi-Puskár J; Steiner L; Klekner A Pathol Oncol Res; 2018 Jan; 24(1):35-43. PubMed ID: 28161812 [TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV. Narsia N; Ramagiri P; Ehrmann J; Kolar Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381 [TBL] [Abstract][Full Text] [Related]
5. Comparative transcriptomics reveals similarities and differences between astrocytoma grades. Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear ribonucleoproteins and their interactors are a major class of deregulated proteins in anaplastic astrocytoma: a grade III malignant glioma. Polisetty RV; Gautam P; Gupta MK; Sharma R; Uppin MS; Challa S; Ankathi P; Purohit AK; Renu D; Harsha HC; Pandey A; Sirdeshmukh R J Proteome Res; 2013 Jul; 12(7):3128-38. PubMed ID: 23741984 [TBL] [Abstract][Full Text] [Related]
7. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196 [TBL] [Abstract][Full Text] [Related]
9. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. Li D; Chen P; Li XY; Zhang LY; Xiong W; Zhou M; Xiao L; Zeng F; Li XL; Wu MH; Li GY OMICS; 2011 Oct; 15(10):673-82. PubMed ID: 21978395 [TBL] [Abstract][Full Text] [Related]
12. The Expression of Leptin and Its Receptor During Tumorigenesis of Diffuse Gliomas such as Astrocytoma and Oligodendroglioma- Grade II, III and IV (NOS). Vokuda RS; B H S; Madhugiri VS; Velusamy SK; Verma SK Asian Pac J Cancer Prev; 2019 Feb; 20(2):479-485. PubMed ID: 30803210 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas. Wang C; Funk CC; Eddy JA; Price ND PLoS One; 2013; 8(10):e76694. PubMed ID: 24146911 [TBL] [Abstract][Full Text] [Related]
14. Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways. Zhang LH; Yang XL; Zhang X; Cheng JX; Zhang W Brain Res; 2011 Jan; 1371():23-31. PubMed ID: 21112319 [TBL] [Abstract][Full Text] [Related]
15. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733 [TBL] [Abstract][Full Text] [Related]
16. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313 [TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Gimenez M; Souza VC; Izumi C; Barbieri MR; Chammas R; Oba-Shinjo SM; Uno M; Marie SK; Rosa JC Proteomics; 2010 Aug; 10(15):2812-21. PubMed ID: 20533335 [TBL] [Abstract][Full Text] [Related]
18. A systemic insight into astrocytoma biology across different grades. Chakraborty S; Ghosh Z J Cell Physiol; 2019 Apr; 234(4):4243-4255. PubMed ID: 30146735 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression. Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]